That's the standard we hold ourselves to, and it's the standard we believe the entire research community should embrace
Scientists at Monash University in Australia developed AOD 9604 in the 1990s specifically as an anti-obesity treatment
Healthcare providers should maintain heightened clinical suspicion for malignancy in patients receiving these peptides and should promptly investigate any concerning clinical findings
Our physicians evaluate your specific needs to determine if this multi-peptide approach is more appropriate than single-peptide therapy for your situation
L-Glutathione reduced plays important biological functions in the organism, including protein and DNA synthesis, enzyme activity, metabolism and cell protection
Safety Data Sheet (SDS) The SDS for Prolaject B12 1000 features first aid measures, handling and storage instructions including recommended PPE, and transport advice